Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1 ; volume:13 ; number:4 ; day:8 ; month:11 ; year:2010 ; pages:1-2 ; date:12.2010
Journal of the International AIDS Society / International AIDS Society ; 13, Heft 4 (8.11.2010), 1-2, 12.2010
- Urheber
-
Maroldo, L.
- Beteiligte Personen und Organisationen
-
Fredrick, LM
Robinson-Morgan, K.
Trinh, R.
Podsadecki, TJ
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-13-S4-P30
- URN
-
urn:nbn:de:1111-2016052057723
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maroldo, L.
- Fredrick, LM
- Robinson-Morgan, K.
- Trinh, R.
- Podsadecki, TJ
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Real-life effectiveness and safety of lopinavir/ritonavir in HIV-infected adults who experienced prior different antiretroviral treatments
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Adherence, coping strategies and depression in highly antiretroviral-experienced patients
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
Dispositional optimism, perceived health competence and adherence in highly antiretroviral-experienced patients
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Real-life effectiveness and safety of lopinavir/ritonavir in HIV-infected adults who experienced prior different antiretroviral treatments
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Adherence, coping strategies and depression in highly antiretroviral-experienced patients
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
Dispositional optimism, perceived health competence and adherence in highly antiretroviral-experienced patients
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Real-life effectiveness and safety of lopinavir/ritonavir in HIV-infected adults who experienced prior different antiretroviral treatments
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Adherence, coping strategies and depression in highly antiretroviral-experienced patients
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients